Abiopharma

Director Henson Christopher L 🟢 acquired 5.9K shares of HOOKER FURNISHINGS Corp (HOFT) Transaction Date: Jun 12, 2026 | Filing ID: 000023

Incyte gibt auf der EHA 2026 neue positive Daten bekannt, wonach INCA033989 bei Patienten mit Myelofibrose und essenzieller Thrombozythämie schnelle, robuste und anhaltende klinische und molekulare Reaktionen erzielte und gut vertragen wurde

Incyte annonce de nouvelles données positives à lEHA 2026 qui indiquent quINCA033989 a obtenu des réponses cliniques et moléculaires rapides, robustes et soutenues et a été bien toléré chez les patients atteints de myélofibrose...

(99% Neutral) ARCADIA BIOSCIENCES, INC. (RKDA) Announces Business Combination

📋 Caulder Alice Lindsay (Officer) plans to sell 609 shares of WORLD ACCEPTANCE CORP (at $181.00 each, total $110K) Filed: Jun 15, 2026 | ID: 004638

Net Asset Value(s)

Director Garafalo Paulette 🟢 acquired 5.9K shares of HOOKER FURNISHINGS Corp (HOFT) Transaction Date: Jun 12, 2026 | Filing ID: 000020

GREEN ANDREW M 🟡 adjusted position in 44.0K shares (2 derivative) of ARTIVION, INC. (AORT) at $20.71 ($2.1M) Transaction Date: Jun 11, 2026 | Filing ID: 043059

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice 15 June 2026

Director Duey Maria C 🟢 acquired 5.9K shares of HOOKER FURNISHINGS Corp (HOFT) Transaction Date: Jun 12, 2026 | Filing ID: 000018

📋 Rothberg Richard J (Officer) plans to sell 20K shares of Dell Technologies Inc. (at $410.00 each, total $8.2M) Filed: Jun 15, 2026 | ID: 004637

📋 MERRIMAN DWIGHT A (Director) plans to sell 6K shares of MongoDB, Inc. (at $348.79 each, total $2.1M) Filed: Jun 15, 2026 | ID: 000112

I risultati dello studio clinico pivotale di Fase 3 frontMIND di Incyte sulla combinazione di Tafasitamab (Monjuvi®/Minjuvi®) presentati in occasione della sessione plenaria del congresso 2026 della European Hematology Association (EHA)...

De resultaten van Incyte’s cruciale fase 3-studie frontMIND naar de combinatiebehandeling met tafasitamab (Monjuvi® /Minjuvi®) werden gepresenteerd tijdens de plenaire sessie van het congres van de European Hematology Association (EHA)...

Los resultados del ensayo fundamental frontMIND fase 3 de la combinación tafasitamab (Monjuvi®/Minjuvi®) de Incyte presentados en el plenario del Congreso de la Asociación Europea de Hematología (EHA) 2026...